À retenir
Pooling 10 placebo-controlled trials in community-dwelling adults over 50, vitamin D alone did not improve grip strength, lean mass or general muscle strength, and scores on the short physical performance battery (SPPB) were slightly lower (mean difference -0.23, 95% CI -0.40 to -0.06, P = 0.007). Heterogeneity was high for some outcomes, and the abstract does not give the vitamin D doses.
Study design
Méta-analyse d’essais
Reading basis
Published abstract
Reading focus
Design & applicability
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Vitamin D is widely proposed as a simple supplement to protect older people from sarcopenia, the loss of muscle mass and function with age. The authors pooled randomized trials to test whether vitamin D given on its own, without other nutrients or exercise, improves muscle and performance measures.
Population et méthode
Systematic review and meta-analysis. The authors searched PubMed, Web of Science, Scopus and the Cochrane Library for randomized controlled trials (RCTs) that compared vitamin D supplementation alone with placebo in adults older than 50. Using a random effects inverse-variance model, they calculated mean differences (MD) in handgrip strength (HGS), the short physical performance battery (SPPB), timed up and go (TUG) and appendicular lean mass (ALM), plus standardized mean differences (SMD) for general muscle strength and general physical performance (composites of all strength and performance outcomes). 10 RCTs were included.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1SPPB scores were lower with vitamin D than with placebo (MD -0.23; 95% CI -0.40 to -0.06; I² = 0%; P = 0.007), meaning slightly worse performance on this combined balance, walking and chair-stand test.
- 2No effect on handgrip strength (MD -0.07 kg; 95% CI -0.70 to 0.55; I² = 51%; P = 0.82) or timed up and go (MD 0.07 s; 95% CI -0.08 to 0.22; I² = 0%; P = 0.35).
- 3No effect on appendicular lean mass (MD 0.06 kg/m²; 95% CI -0.32 to 0.44; I² = 73%; P = 0.77).
- 4Composite outcomes were also null: general muscle strength (SMD -0.01; 95% CI -0.17 to 0.15; I² = 42%; P = 0.90) and general physical performance (SMD -0.02; 95% CI -0.23 to 0.18; I² = 71%; P = 0.83).
Limites et incertitude
- 1Only 10 trials, with moderate to high heterogeneity for lean mass (I² = 73%), general physical performance (71%) and grip strength (51%), so the pooled estimates are imprecise.
- 2The abstract does not report vitamin D doses, baseline vitamin D levels or trial length, so it cannot tell whether people who were deficient benefit.
- 3The lower SPPB score is a small difference seen in one outcome among several tested, and the authors call for work on its separate components (mobility and balance).
- 4Participants were community-dwelling adults over 50 taking vitamin D alone, so the findings do not cover combined treatment with exercise or protein. This reading is based on the abstract only.
Mise en perspective
Taking vitamin D by itself should not be expected to preserve muscle strength or lean mass in healthy older adults. This does not address people with a diagnosed deficiency or other bone-health reasons for supplementing, and decisions about supplements belong with a clinician.
Vos données
Muscle health can be followed through grip strength, a sit-to-stand test or walking speed, and a smart scale's lean-mass estimate, but consumer body-composition readings are rough and vary with hydration. Compare the same measures under the same conditions and device over months.
Comprendre ce type de preuve
Pooling trials can improve precision, but compare populations, controls, bias and uncertainty. Network rankings include indirect evidence and do not identify a universal best treatment.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
Vitamin D supplementation is proposed as a potentially effective nutritional intervention to mitigate the risk of sarcopenia. The aim of this systematic review and meta-analysis was to investigate the impact of vitamin D supplementation monotherapy on indices of sarcopenia in community-dwelling older adults.
Methods
A comprehensive search of the literature was conducted in PubMed, Web of Science, Scopus, and Cochrane Library. Eligible randomized controlled trials (RCTs) compared the effect of vitamin D supplementation (as monotherapy) with placebo on indices of sarcopenia in older (>50 years) adults. Using the random effects inverse-variance model, we calculated the mean difference (MD) in handgrip strength (HGS), short physical performance battery (SPPB), timed up and go (TUG), and appendicular lean mass (ALM) between groups. We also calculated the standardized mean difference (SMD) in general muscle strength and general physical performance (composite plot of all muscle strength and physical performance outcomes, respectively) between groups.
Results
Ten RCTs were included in the meta-analysis. A significant decrease in SPPB scores was observed with vitamin D supplementation compared with placebo (MD: -0.23; 95% CI -0.40 to -0.06; I^(2) = 0%; P = 0.007). Vitamin D supplementation conferred no effect on HGS (MD: -0.07 kg; 95% CI -0.70 to 0.55; I^(2) = 51%, P = 0.82), TUG (MD: 0.07 s; 95% CI -0.08 to 0.22; I^(2) = 0%, P = 0.35), ALM (MD: 0.06 kg/m^(2) ; 95% CI: -0.32 to 0.44; I^(2) = 73%, P = 0.77), general muscle strength (SMD: -0.01; 95% CI -0.17 to 0.15; I^(2) = 42%, P = 0.90), or general physical performance (SMD: -0.02; 95% CI -0.23 to 0.18; I^(2) = 71%, P = 0.83).
Conclusions
Vitamin D supplementation did not improve any sarcopenia indices in community-dwelling older adults and may compromise some aspects of physical performance. Future studies are warranted to investigate the impact of vitamin D supplementation on individual indices of SPPB, including mobility and balance, in older adults.
Sources et attribution
Effect of vitamin D monotherapy on indices of sarcopenia in community-dwelling older adults: a systematic review and meta-analysis.
Prokopidis K, Giannos P, Katsikas Triantafyllidis K, Kechagias KS, Mesinovic J, Witard OC, Scott D.
Journal of cachexia, sarcopenia and muscle · 2022-03-08
DOI: 10.1002/jcsm.12976 ↗PubMed · 35261183 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

